Pompey, France, January 16, 2014 - Novasep, a leading supplier of manufacturing solutions to the life sciences industry, today announces it has appointed Thierry van Nieuwenhove as president of the Synthesis Business Unit. Van Nieuwenhove's arrival completes Novasep's executive committee. With its full executive committee (COMEX) now on board, Novasep achieves another key milestone in its strategic development.
Educated as a bio-engineer, Van Nieuwenhove, 40, holds a masters degree in chemistry and biochemistry from the Catholic University of Louvain, Belgium. He joins Novasep from Ajinomoto-Omnichem, a European synthetic molecules custom manufacturing organization (CMO) owned by a top Japanese firm, where he held consecutive positions as director, then general manager and member of the board. His skill set includes driving business unit growth, leading global teams including sales and business development, R&D, supply chain and purchasing, as well as mergers and acquisitions.
"We are thrilled to welcome Thierry to Novasep as president of the Synthesis Business Unit," said Michel Spagnol, CEO of Novasep. "His broad experience in driving multicultural custom synthesis businesses will complement our COMEX skills perfectly. Thierry possesses the dynamics to boost Novasep's CMO business in all our key markets."
"I am very pleased to join Novasep," said Thierry Van Nieuwenhove. "With its unique pool of specialized technologies and talents, Novasep is well positioned for growth as a top tier service provider for the life sciences industry. The group as a whole has tremendous opportunities to develop. Really innovative solutions can come out from the cross-fertilization of its several specialized technologies and application markets that will build future Novasep expertise. I am excited to be part of it."
Novasep is a global provider of cost-effective and sustainable solutions to produce active molecules at the required purity. Novasep's unique offering includes process development services, purification equipment and turnkey processes, contract manufacturing services and complex active molecules to serve pharmaceutical, biopharmaceutical, fine chemical, food and functional ingredients as well as bio-sourced chemicals and bio-industries.
To view the original press release: http://www.ala.com/article.php?id=332
ANDREW LLOYD & ASSOCIATES
Tel UK: +44 1273 675100
Tel France: +33 1 56 54 07 00
Tel US: +1 617 202 44 91
INTERNATIONAL TECHNOLOGY MARKETS, STRATEGY & COMMUNICATION